You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Mondo term: G6PD deficiency, with chronic non-spherocytic hemolytic anemia (CNSHA) (MONDO:0010480)
Suggested revision of textual definition. Please include a source, like a PubMed ID (in the format PMID:#######)
“An X-linked genetic condition caused by alterations in the gene G6PD that result in severely decreased activity levels of the enzyme glucose-6-phosphate dehydrogenase. Individuals with hemizygous G6PD variants associated with chronic nonspherocytic hemolytic anemia (CNSHA) have CNSHA. Individuals with G6PD variants that cause CNSHA are at risk for acute hemolytic anemia in response to certain medication exposures, chemical exposures, infections, or consumption of fava beans.”
Mondo term: G6PD deficiency, with chronic non-spherocytic hemolytic anemia (CNSHA) (MONDO:0010480)
Suggested revision of textual definition. Please include a source, like a PubMed ID (in the format PMID:#######)
“An X-linked genetic condition caused by alterations in the gene G6PD that result in severely decreased activity levels of the enzyme glucose-6-phosphate dehydrogenase. Individuals with hemizygous G6PD variants associated with chronic nonspherocytic hemolytic anemia (CNSHA) have CNSHA. Individuals with G6PD variants that cause CNSHA are at risk for acute hemolytic anemia in response to certain medication exposures, chemical exposures, infections, or consumption of fava beans.”
Your nano-attribution (ORCID)
If you don't have an ORCID, you can sign up for one here
ClinGen G6PD VCEP: https://www.clinicalgenome.org/affiliation/50147/
The text was updated successfully, but these errors were encountered: